Zepp Health Corporation (ZEPP)
NYSE: ZEPP · Real-Time Price · USD
4.720
-0.200 (-4.07%)
Sep 9, 2026, 9:49 AM EDT - Market open
Zepp Health Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 276.03 | 258.9 | 182.6 | 352.86 | 613.64 | 983.87 |
Revenue Growth | 38.05% | 41.78% | -48.25% | -42.50% | -37.63% | -0.16% |
Gross Profit Gross Profit Growth | 106.5 | 99.19 | 70.23 | 92.36 | 118.86 | 205.53 |
Operating Income Operating Income Growth | -34.75 | -29.23 | -47.25 | -30.45 | -61.86 | 14.79 |
Net Income Net Income Growth | -43.56 | -40.07 | -75.73 | -31.02 | -43.24 | 21.69 |
Earnings Per Share EPS Growth | -2.79 | -2.56 | -4.68 | -2.08 | -2.88 | 1.31 |
EPS Growth | - | - | - | - | - | -39.27% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Europe Europe Growth | 110.27 | 74.88 | 134.55 | 185.24 |
Others Others Growth | 10.3 | 4.82 | 4.21 | 0.8 |
Asia-Pacific Asia-Pacific Growth | 91.48 | 75.53 | 180.97 | 373.99 |
North America Excluding United States North America Excluding United States Growth | 3.23 | 0.18 | - | - |
United States United States Growth | 43.62 | 27.19 | - | - |
Total Total Growth | 258.9 | 182.6 | 352.86 | 613.64 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 69.66 | 57.05 | 92.07 | 138.82 | 133.52 | 235 |
Total Debt Total Debt Growth | 134.31 | 117.24 | 120.46 | 128.78 | 184.16 | 189.85 |
Net Cash (Debt) Net Cash Growth | -64.64 | -60.19 | -28.39 | 10.04 | -50.64 | 45.15 |
Net Cash Growth | - | - | - | - | - | -81.20% |
Net Cash Per Share Net Cash Per Share Growth | -4.08 | -3.79 | -1.75 | 0.66 | -3.29 | 2.73 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | - | -25.69 | -24.39 | 42.6 | -117.11 | -36.59 |
Capital Expenditures CapEx Growth | - | -0.52 | -1.4 | -1.6 | -1.21 | -7.25 |
Free Cash Flow Free Cash Flow Growth | - | -26.21 | -25.8 | 41.01 | -118.32 | -43.84 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 38.58% | 38.31% | 38.46% | 26.17% | 19.37% | 20.89% |
Operating Margin | -12.59% | -11.29% | -25.88% | -8.63% | -10.08% | 1.50% |
Pretax Margin | -14.87% | -14.50% | -34.02% | -9.50% | -8.67% | 2.36% |
Profit Margin | -15.78% | -15.48% | -41.47% | -8.79% | -7.05% | 2.21% |
FCF Margin | - | -10.12% | -14.13% | 11.62% | -19.28% | -4.46% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | - | 14.66 |
Forward PE | - | 14.00 | 14.00 | 11.83 | 8.54 | 6.96 |
P/FCF Ratio | - | - | - | 2.11 | - | - |
PS Ratio | 0.26 | 1.50 | 0.21 | 0.25 | 0.15 | 0.32 |